Our firm represented BiomX in a venture debt transaction of up to $ 30 million signed with Hercules Capital Inc. as the lender.
BiomX, a Delaware company whose shares are traded on the New York Stock Exchange and on the Tel Aviv Stock Exchange. BiomX is developing treatments that use bacteria-attacking viruses to treat a variety of illnesses.
BiomX was represented by partners Shy Baranov, Dubi Gross, Idan Baki and Assaf Prussak, along with Associate Laura Hadar, Associate Yarden Wulkan Rosenman and Senior Associate Nir Moses.
